Predictors of poor coronary collateral development in patients with stable coronary artery disease: Neutrophil-to-lymphocyte ratio and platelets

Anadolu Kardiyoloji Dergisi

Volumn 15, Issue 3, 2015, Pages 218-223

  Akın, Fatih ^a   Ayça, Burak ^b   Çelik, Ömer ^c   Şahin, Cem ^a  

^a MUGLA SITKI KOCMAN UNIVERSITY   (Turkey)

^b Bagcilar Education and Research Hospital   (Turkey)

^c Istanbul Mehmet Akif Ersoy Cardiovascular Surgery Education and Research Hospital   (Turkey)

Author keywords

Coronary collateral circulation; Hematologic parameters; Neutrophil to lymphocyte ratio; Uric acid

Indexed keywords

HEMOGLOBIN; TRIACYLGLYCEROL; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CORONARY ARTERY COLLATERAL CIRCULATION; CORONARY ARTERY DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL LYMPHOCYTE RATIO; OBSERVATIONAL STUDY; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SMOKING; COLORIMETRY; HEMATOLOGICAL PARAMETERS; RED BLOOD CELL DISTRIBUTION WIDTH; URIC ACID BLOOD LEVEL; ANGINA PECTORIS; BLOOD; COHORT ANALYSIS; COLLATERAL CIRCULATION; COMPLICATION; EVALUATION STUDY; LYMPHOCYTE; MIDDLE AGED; NEUTROPHIL; PATHOPHYSIOLOGY; PREDICTIVE VALUE; SEVERITY OF ILLNESS INDEX;

ANGINA PECTORIS; CASE-CONTROL STUDIES; COHORT STUDIES; COLLATERAL CIRCULATION; CORONARY ARTERY DISEASE; FEMALE; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; NEUTROPHILS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84979095950     PISSN: 13028723     EISSN: 13080032     Source Type: Journal    
DOI: 10.5152/akd.2014.5263     Document Type: Article

References (44)

1. Cohen M, Rentrop K P. Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary artery occlusion in human subjects: a prospective study. Circulation 1986; 74: 469-76.
2. Williams DO, Amsterdam EA, Miller RR, Mason DT. Functional significance of coronary collateral vessels in patients with acute myocardial infarction: relation to pump performance, cardiogenic shock and survival. Am J Cardiol 1976; 37: 345-51.
3. Billinger M, Kloos P, Eberli FR, Windecker S, Meier B, Seiler C. Physiologically assessed coronary collateral flow and adverse cardiac ischemic events: a follow-up study in 403 patients with coronary artery disease. J Am Coll Cardiol 2002; 40: 1545-50.
4. Abacı A, Oğuzhan A, Kahraman S, Eryol NK, Ünal S, Arınç H, et al. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 1999; 99: 2239-42.
5. Kocaman SA, Arslan U, Tavil Y, Okuyan H, Abacı A, Çengel A. Increased circulating monocyte count is related to good collateral development in coronary artery disease. Atherosclerosis 2008; 197: 753-6.
6. Schultz A, Lavie L, Hochberg I, Beyar R, Stone T, Skorecki K, et al. Interindividual heterogeneity in the hypoxic regulation of VEGF: significance for the development of the coronary artery collateral circulation. Circulation 1999; 100: 547-52.
7. Mitsuma W, Kodama M, Hirono S, Ito M, Ramadan MM, Tanaka K, et al. Angiopoietin-1, angiopoietin-2 and tie-2 in the coronary circulation of patients with and without coronary collateral vessels. Circ J 2007; 71: 343-7.
8. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-95.
9. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105-87.
10. Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Kirkman MS, et al. Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus. Diabetes Care 2011; 34: e61-e99.
11. Genest J, McPherson R, Frohlich J, Anderson T, Campbell N, Carpentier A, et al. 2009 Canadian Cardiovascular Society/ Canadian guidelines for the diagnosis and treatment of dyslipid-emia and prevention of cardiovascular disease in the adult - 2009 recommendations. Can J Cardiol 2009; 25: 567-79.
12. Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser 1968; 405: 5-37.
13. Rentrop K P, Cohen M, Blanke H, Phillips RA. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985; 5: 587-92.
14. Seiler C, Stoller M, Pitt B, Meier P. The human coronary collateral circulation: development and clinical importance. Eur Heart J 2013; 34: 2674-82.
15. Meier P, Hemingway H, Lansky AJ, Knapp G, Pitt B, Seiler C. The impact of the coronary collateral circulation on mortality: a meta-analysis. Eur Heart J 2012; 33: 614-21.
16. Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868-74.
17. Chia S, Nagurney JT, Brown D F, Raffel OC, Bamberg F, Senatore F, et al. Association of leukocyte and neutrophil counts with infarct size, left ventricular function and outcomes after percutaneous coronary intervention for ST-elevation myocardial infarction. Am J Cardiol 2009; 103: 333-7.
18. Horne BD, Anderson JL, John JM, Weaver A, Bair TL, Jensen KR, et al. Intermountain Heart Collaborative Study Group. Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol 2005; 45: 1638-43.
19. Arbel Y, Finkelstein A, Halkin A, Birati E Y, Revivo M, Zuzut M, et al. Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiog-raphy. Atherosclerosis 2012; 225: 456-60.
20. Lindner V, Maciag T. The putative convergent and divergent natures of angiogenesis and arteriogenesis. Circ Res 2001; 89: 747-9.
21. Verma S, Wang CH, Li SH, Dumont AS, Fedak PW, Badiwala MV, et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 2002; 106: 913-9.
22. Schneeweis C, Gräfe M, Bungenstock A, Spencer-Hänsch C, Fleck E, Goetze S. Chronic CRP-exposure inhibits VEGF induced endothelial cell migration. J Atheroscler Thromb 2010; 17: 203-12.
23. Singh SK, Suresh M V, Voleti B, Agrawal A. The connection between C-reactive protein and atherosclerosis. Ann Med 2008; 40: 110-20.
24. Fichtlscherer S, Rosenberger G, Walter DH, Breuer S, Dimmeler S, Zeiher AM. Elevated C-reactive protein levels and impaired endo-thelial vasoreactivity in patients with coronary artery disease. Circulation 2000; 102: 1000-6.
25. Verma S, Kuliszewski MA, Li SH, Szmitko PE, Zucco L, Wang CH, et al. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation 2004; 109: 2058-67.
26. Nabata A, Kuroki M, Ueba H, Nabata A, Kuroki M, Ueba H, et al. C-reactive protein induces endothelial cell apoptosis and matrix metalloproteinase-9 production in human mononuclear cells: Implications for the destabilization of atherosclerotic plaque. Atherosclerosis 2008; 196: 129-35.
27. Kerner A, Gruberg L, Goldberg A, Roguin A, Lavie P, Lavie L, et al. Relation of C-reactive protein to coronary collaterals in patients with stable angina pectoris and coronary artery disease. Am J Cardiol 2007; 99: 509-12.
28. Kadı H, Ceyhan K, Karayakalı M, Koç F, Çelik A, Önalan O. The relationship between coronary collateral circulation and blood high-sensitivity C-reactive protein levels. Turk Kardiyol Dern Ars 2011; 39: 23-8.
29. Zorkun C, Akkaya E, Zorlu A, Tandoğan İ. Determinants of coronary collateral circulation in patients with coronary artery disease. Anatol J Cardiol 2013; 13: 146-51.
30. Güleç S, Özdemir AO, Maradit-Kremers H, Dinçer İ, Atmaca Y, Erol C. Elevated levels of C-reactive protein are associated with impaired coronary collateral development. Eur J Clin Invest 2006; 36: 369-75.
31. Seiler C, Pohl T, Billinger M, Meier B. Tumour necrosis factor alpha concentration and collateral flow in patients with coronary artery disease and normal systolic left ventricular function. Heart 2003; 89: 96-7.
32. Güray U, Erbay AR, Güray Y, Yılmaz MB, Boyacı AA, Şaşmaz H, et al. Poor coronary collateral circulation is associated with higher con-centrations of soluble adhesion molecules in patients with single-vessel disease. Coron Artery Dis 2004; 15: 413-7.
33. Dincer İ, Ongun A, Turhan S, Özdöl C, Ertaş F, Erol C. Effect of statin treatment on coronary collateral development in patients with diabetes mellitus. Am J Cardiol 2006; 97: 772-4.
34. van der Hoeven NW, Teunissen P F, Werner GS, Delewi R, Schirmer SH, Traupe T, et al. Clinical parameters associated with collateral development in patients with chronic total coronary occlusion. Heart 2013; 99: 1100-5.
35. Matsunaga T, Wartlier DC, Weihrauch DW, Moniz M, Tessmer J, Chilian WM. Ischaemia-induced coronary collateral growth is dependent on vascular endothelial growth factor and nitric oxide. Circulation 2000; 102: 3098-103.
36. Homma Y. Predictors of atherosclerosis. J Atheroscler Thromb 2004; 11: 265-70.
37. Kasapkara HA, Topsakal R, Yarlioglues M, Yarlioglues G, Doğdu O, Ardıç I, et al. Effects of serum uric acid levels on coronary collateral circulation in patients with non-ST elevation acute coronary syndrome. Coron Artery Dis 2012; 23: 421-5.
38. Uysal OK, Şahin DY, Duran M, Türkoğlu C, Yıldırım A, Elbasan Z, et al. Association between uric acid and coronary collateral circulation in patients with stable coronary artery disease. Angiology 2014; 65: 227-31.
39. Hsu PC, Su HM, Lin TH. Association between coronary collaterals and serum uric acid level in Chinese population with acute coronary syndrome. Angiology 2013; 64: 323-4.
40. Ege MR, Açıkgöz S, Zorlu A, Sincer I, Güray Y, Güray U, et al. Mean platelet volume: an important predictor of coronary collateral development. Platelet 2013; 24: 200-4.
41. Duran M, Uysal OK, Günebakmaz O, Yılmaz Y, Akın F, Baran O, et al. Increased red cell distribution width level is associated with absence of coronary collateral vessels in patients with acute coronary syndromes. Turk Kardiyol Dern Ars 2013; 41: 399-405.
42. Kadı H, Özyurt H, Ceyhan K, Koç F, Çelik A, Burucu T. The relationship between high-density lipoprotein cholesterol and coronary collateral circulation in patients with coronary artery disease. J Investig Med 2012; 60: 808-12.
43. Koerselman J, de Jaegere PP, Verhaar MC, Grobbee DE, van der Graaf Y; SMART Study Group. Coronary collateral circulation: the effects of smoking and alcohol. Atherosclerosis 2007; 191: 191-8.
44. Kadı H, Ceyhan K, Söğüt E, Koç F, Çelik A, Önalan O, Şahin S. Mildly decreased glomerular filtration rate is associated with poor coronary collateral circulation in patients with coronary artery disease. Clin Cardiol 2011; 34: 617-21.